Nav: Home

Scientists propose nanoparticles that can treat cancer with magnetic fluid hyperthermia

March 06, 2020

A group of Russian scientists have synthesized manganese-zinc ferrite nanoparticles that can potentially be used in cancer treatment. Due to their unique magnetic properties, the particles can serve as deactivators of affected cells while having almost no negative impact on healthy tissues. The results have been published in the Journal of Sol-Gel Science and Technology.

One of the most important global goals in today's medicine is finding ways to combat cancer. Currently, there are several kinds of treatments with differing effectiveness and various side effects. In most cases, the treatment causes harmful impact not only to cancer cells but also the adjacent healthy tissues or the body at large.

Magnetic fluid hyperthermia is a promising method that can help alleviate the side effects of cancer treatment. This method involves introducing a magnetic nanoparticles-containing sol into a tumor followed by its exposure to a variable magnetic field. This causes the heating of the nanoparticles and leads to the deactivation of cancer cells. However, the majority of the materials used for this purpose are toxic to the body. What is more, the particles continue to heat up to relatively high temperatures, which entails serious damage to healthy tissues.

These problems could be solved by the application of special nanoparticles which can change their magnetic properties depending on the temperature. In physics, there is such a notion as the Curie temperature (also known as the Curie point), which is the temperature at which a sharp decrease in magnetization is observed.

"When the Curie temperature is reached, a ferromagnetic changes into a paramagnetic, consequently the particles cease to be as susceptible to the magnetic field and their further heating stops," explains Vasilii Balanov, a Master's student at ITMO University and one of the research's authors. "When the temperature drops back again, the particles resume their heating. Essentially, we observe a self-management of temperature in a narrow range. If we select a composition that experiences such a transition at the temperature we need, then it could prove effective for magnetic fluid hyperthermia."

Choosing the material, the scientists opted for ferrites - compounds of iron oxide (III)Fe2O3 with oxides of other metals. Generally, thanks to their properties, these materials are widely applied in computer technologies, but, as it turned out, they can also be used for medical purposes.

"We took the particles with the general formula Zn(x)Mn(1-x)Fe2O4, in which zinc and manganese are selected in a certain proportion," expounds Vasilii Balanov. "They don't have a toxic effect on the body, and with the right ratio of manganese and zinc we were able to achieve a Curie temperature in the range of 40-60 degrees Celsius. This temperature allows us to deactivate cancer cells, concurrently, the short-term thermal contact is relatively harmless to healthy tissues."

As of now, the scientists have already synthesized the nanoparticles and studied their magnetic properties. The experiments confirmed that the material doesn't heat up above 60 degrees Celsius when exposed to a variable magnetic field. Coming next will be the experiments on living cells and, if these are successful, on animals.

ITMO University

Related Cancer Cells Articles:

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.
Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.
First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.
Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.
Plant-derived SVC112 hits cancer stem cells, leaves healthy cells alone
Study shows Colorado drug SVC112 stops production of proteins that cancer stem cells need to survive and grow.
Changes in the metabolism of normal cells promotes the metastasis of ovarian cancer cells
A systematic examination of the tumor and the tissue surrounding it -- particularly normal cells in that tissue, called fibroblasts -- has revealed a new treatment target that could potentially prevent the rapid dissemination and poor prognosis associated with high-grade serous carcinoma (HGSC), a tumor type that primarily originates in the fallopian tubes or ovaries and spreads throughout the abdominal cavity.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
White blood cells related to allergies may also be harnessed to destroy cancer cells
A new Tel Aviv University study finds that white blood cells which are responsible for chronic asthma and modern allergies may be used to eliminate malignant colon cancer cells.
Conversion of breast cancer cells into fat cells impedes the formation of metastases
An innovative combination therapy can force malignant breast cancer cells to turn into fat cells.
Breast cancer cells in mice tricked into turning into fat cells
As cancer cells respond to cues in their microenvironment, they can enter a highly plastic state in which they are susceptible to transdifferentiation into a different type of cell.
More Cancer Cells News and Cancer Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at